ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Fresenius Kabi clinical trials

Part of Fresenius SE & Co. KGaA, which holds 100% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 90 studies whose lead sponsor is Fresenius Kabi or one of 9 companies grouped under it. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 29, 2026.

Our grouping of 11 registry names, not the registry’s. See them and correct one ↓

Pipeline: 1 program

Each counted once: 1 with a study Fresenius Kabi leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Fresenius Kabi’s own registered studies; Fresenius Kabi’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Fresenius Kabi’s studies test, most open studies first — 18 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 8 more

Coming up

3 of Fresenius Kabi’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 90 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now89%Recruiting 7 · Not yet recruiting 1
  • Under way, not recruiting22%
  • Completed6774%
  • Stopped early1112%Terminated 9 · Withdrawn 2
  • Status unknown or other22%

Phase

  • Phase 321
  • Phase 118
  • Phase 417
  • Phase 21

Where

  • Germany18
  • Poland14
  • France12
  • United States11
  • China9
  • Czechia8

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 917
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Fresenius Kabi.

  • Fresenius Kabi
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    51 studies
  • mAbxience Research S.L.
    Acquired — became part of Fresenius Kabi, Aug 1, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    15 studies →
  • Fresenius Kabi SwissBioSim GmbH
    Acquired — became part of Fresenius Kabi, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Fresenius Kabi Taiwan Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Fenwal, Inc.
    Acquired — became part of Fresenius Kabi, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Fresenius Kabi Japan
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Sino-Swed Pharmaceutical Corporation
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Fresenius Kabi USA, LLC
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study
  • Fresenius Kabi, France
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Fresenius Kabi Oncology Ltd.
    Acquired — became part of Fresenius Kabi, 2008 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Fresenius Kabi leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 90. Browse all 90 →